ISPUB.com / IJGE/8/1/3836
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Gastroenterology
  • Volume 8
  • Number 1

Original Article

ERCP in a district general hospital in England: a review of 1550 procedures over nine years

J Penston, P Southern, V Penston, J Daws

Keywords

cannulation rates, complications, endoscopic retrograde cholangio-pancreatography, ercp

Citation

J Penston, P Southern, V Penston, J Daws. ERCP in a district general hospital in England: a review of 1550 procedures over nine years. The Internet Journal of Gastroenterology. 2008 Volume 8 Number 1.

Abstract


Objectives: To describe the practice of ERCP in a district general hospital.Design: Descriptive study with prospective data collection from all patients undergoing ERCP between 1997 and 2006.Endpoints: The main outcomes were technical success (cannulation rates and therapeutic success rates) and safety (complication rate).Results: Technical success rates were high: cannulation of common bile duct was achieved in 95% of all 1550 ERCPs, increasing to 98% during 2001-2006; high success rates were also achieved for sphincterotomy, pre-cut incision, stent insertion and stone removal. The complication rate was low: acute pancreatitis occurred in 3%, perforation in 0.3% and haemorrhage in 0.4%, with a decrease in complications over time; procedure-related mortality was 0.2%. During the study period, the success rates for cannulation and therapeutic procedures increased, while complications decreased.Conclusions: ERCP in a district general hospital was associated with a high degree of technical success and a low risk of complications.

 

Introduction

Endoscopic retrograde cholangio-pancreatography (ERCP) is a technically difficult procedure that is associated with a substantial risk of complications and may result in death. Awareness of these problems has led to recommendations designed to restrict the number of procedures by careful selection of patients and the use of alternative methods of investigation. 1 However, there is evidence that patients continue to be subjected inappropriately to ERCP. 2

A recent extensive audit by the British Society of Gastroenterology 3 indicated that approximately 48,000 ERCPs are performed each year in the United Kingdom. Given that the risk of complications is 5-10% and the mortality is 0.3-1.0%, it follows that about 2400-4800 patients suffer adverse events and up to 480 die every year directly as a result of ERCP. If patients are to participate in decisions regarding their management, then they must be made aware of the success rates of the procedure, as well the magnitude of the risks of complications.

This study describes the practice of ERCP over a period of nine years in a district general hospital in England with particular emphasis on the success rates of the technical aspects of the procedure and the rates of complications.

Methods

Since June 1997, patients undergoing ERCP have been assessed by the single consultant gastroenterologist performing the procedure (JP). This includes a detailed history and examination, together with a review of all relevant investigations. Patients are given a full explanation of the procedure and advised of the risks of complications. They are also provided with a booklet about ERCP and advised to read it carefully before giving their informed consent.

All patients are given prophylactic antibiotics, usually cefuroxime 750mg intravenously, approximately one hour before the procedure. ERCPs are performed in the radiology department using Pentax duodenoscopes. Patients receive a local anaesthetic with lidocaine throat spray followed by intravenous sedation with midazolam and pethidine. They are monitored with pulse oximetry throughout the procedure by a fully qualified nurse. Afterwards, they are transferred to the ward for observation.

Data have been collected prospectively on all patients who have undergone ERCP since 1997. Immediately after the procedure, demographic details, together with information related to indications, sedation, endoscopic and radiological findings, as well as a description of therapeutic interventions, are recorded on a computer file. The number of data fields was increased in 2001 and, consequently, not all data are available for the entire study period. However, information relating to the most important aspects of ERCP – in other words, cannulation success rates, therapeutic procedure success rates and complications – are available in all cases.

All patients are reviewed by the consultant endoscopist 6-8 hours after the procedure and again the following morning. Data relating to complications are recorded in the medical records which are reviewed at intervals so that the computer files may be updated with this information.

Between 1997 and 2001, the data set was regularly assessed for accuracy by the audit department before presentation at internal audit meetings. Subsequently, information related to complications has been collected by both the consultant gastroenterologist and junior staff to check on the accuracy of the data.

All patients undergoing ERCP – defined as any attempt at intubation of the oesophagus with the duodenoscope – by a single gastroenterologist at Scunthorpe General Hospital between June 1997 and May 2006 have been included in this analysis. Therefore, this paper presents the results of an intention-to-treat analysis.

Results

Patients

The total number ERCPs performed during the period 1997-2006 was 1550 with a trend towards fewer procedures over time. (Fig. 1). The mean age of patients was 67 years (range 18-97 years) and 58% were female. Twenty-eight percent of ERCPs were repeat procedures.

Between 2001 and 2006, 96% of patients were reviewed by the consultant performing the ERCP before the procedure. In the remaining cases, the patients had been referred after assessment by another consultant gastroenterologist. All 1550 patients were reviewed by the consultant endoscopist 6-8 hours after ERCP.

Figure 1. Number of ERCPs performed per year, 1997 – 2006.

Figure 1

Sedation

Data relating to sedation and patients’ cooperation with the procedure were available between 2001 and 2006. All patients were sedated with intravenous midazolam and >95% also received pethidine. General anaesthesia was used in 3% of patients.

Sedation was judged to be effective in 41% of ERCPs. However, in more than half of cases, cooperation was recorded as either fair or poor, and the failure to achieve adequate sedation frequently hampered diagnostic cannulation and therapeutic procedures.

Indications

Data relating to the major indication for ERCP – without regard to the presence or absence of additional indications – were available for the entire study period. The most frequently recorded major indications were obstructive jaundice (41%) and abdominal pain (28%). Since 1999, no ERCPs were performed for abdominal pain except when accompanied by objective evidence of biliary tract obstruction, in particular, deranged liver function tests or dilated ducts.

When the data for major and minor complications were combined for the period 2001-2006, the most frequently observed indications for ERCP were obstructive jaundice (47%), abdominal pain (55%) and dilatation of the biliary tract (52%). Five per cent of procedures were performed for acute pancreatitis.

Endoscopic aspects

The oesophagus was successfully intubated in all 1550 ERCPs. In six patients (0.4%), intubation was difficult but was successfully achieved by placement of a guidewire with a gastroscope followed by intubation with the duodenoscope over the wire.

The second part of the duodenum was reached in 1545 procedures (99.7%). On one occasion, a benign stricture of the pylorus was dilated in order to gain access to the duodenum.

Data relating to the papilla are available only for the period 2001-2006. Excluding one case of a previous choledocho-enterostomy in which the common hepatic duct was successfully cannulated, the papilla was identified in 827/833 procedures (99.3%). The papilla was normal in appearance in 55%, while the remainder were recorded as showing inflammation or scarring (13%), tumour (4%) or a previous sphincterotomy (23%). The position of the papilla was normal in 73%; in 14%, it was located in an abnormal position, either high in the second part or displaced by underlying disease; the papilla was involved in a duodenal diverticulum in 12%.

Cannulation and diagnostic findings in the biliary tract

In all ERCPs, the intention was to cannulate the common bile duct. Overall, this was successfully achieved in 1475/1550 (95%) procedures. However, there was a marked improvement in cannulation rates during the first three years from 82% to 97% and, over the last five years, the success rate in 834 ERCPs was 98% on a strict intention-to-treat analysis. (Fig. 2)

Figure 2. Success rate (%) for common bile duct cannulation by year

Figure 2

Between 1997 and 2006, there was a downward trend in the proportion of normal cholangiograms. (Fig. 3) Comparing the first two years with the final two years of the study period, normal cholangiograms decreased from 54% to 16%. During the period 2001-2006, the most common abnormalities detected on cholangiography were biliary tract dilatation (65%), strictures (33%) and choledocholithiasis (38%).

Figure 3. Normal cholangiograms (% of procedures) per year.

Figure 3

Cannulation and diagnostic findings in pancreas

Given the developments in alternative diagnostic methods for investigation of the pancreas and the danger of ERCP-induced acute pancreatitis, cannulation of the pancreatic duct was usually not deliberately undertaken. However, pancreatograms were often obtained with the initial injection of contrast. Overall, visualisation of the pancreatic duct was obtained in 874/1550 (56%) procedures. There was, though, a fall in the frequency of pancreatograms from 70% in the first year to 55% in the final year of the analysis. Of 874 pancreatograms, 79% were normal, the remainder showing strictures of the pancreatic duct, changes of chronic pancreatitis or pancreas divisum.

Therapeutic procedures

Sphincterotomy and Pre-cut incision

Sphincterotomy was attempted in 844 of 1550 (54%) procedures. This proportion increased from 44% in the period 1997-2001 to 63% in 2001-2006. (Fig 4)

Pre-cut, or needle-knife sphincterotomy, was attempted in 264 of 1550 (17%) procedures. (Fig. 4) Success, defined as obtaining access to the common bile duct, was achieved in 216 of 264 (82%) attempts. Successful pre-cut incision increased from 71% in the period 1997-2001 to 90% in 2001-2006. (Fig. 5)

Figure 4. Percentage of ERCPs involving therapeutic procedures by year

Figure 4

Stent insertion

Overall, stent placement in the biliary tract was attempted in 509 of 1550 (33%) procedures and this proportion increased over time. (Fig. 4) Successful insertion of the stent was achieved in 96% of ERCPs in which it was required.

Figure 5. Success rates (%) of pre-cut incision by year.

Figure 5

Stone extraction

Stone extraction was attempted in 432 of 1550 (27%) ERCPs and this proportion increased from 21% in the period 1997-2001 to 33% in 2001-2006. (Fig. 4) Complete or partial clearance were achieved in 300 (78%) and 59 (14%), respectively. Stone extraction failed in 32 (8%). There was an improvement over time with complete clearance achieved in 68% of cases in 1997-2001 compared with 83% in 2001-2006. (Fig. 6)

Figure 6. Success rates (% complete clearance) of stone extraction

Figure 6

Complications

The complications of ERCP were graded as mild, moderate or severe in line with previous recommendations. 4

Pancreatitis

The most commonly observed complication of ERCP was acute pancreatitis which occurred in 51 of 1550 (3%) procedures. (Fig. 7) Of these 51 cases, 36 (71%) were mild and 7 (14%) were severe. One of the seven patients with severe pancreatitis died as a result of this complication. The proportion of ERCPs followed by this complication decreased sharply from 6% in the period 1997-2001 to 1% in 2001-2006.

Infection

Infection was recorded as a complication of ERCP in 10/1550 (0.6%) of procedures. (Fig. 7) In only one case was this classified as severe. There were no deaths due to infective complications of ERCP.

Figure 7. Complications during the entire study period, defined by type and severity

Figure 7

Haemorrhage

Haemorrhage occurred after seven of 1550 (0.4%) ERCPs. (Fig. 7) In two of these cases, bleeding was severe and required surgery. There was no mortality from haemorrhage after ERCP.

Perforation

Perforation occurred after five of 1550 (0.3%) ERCPs. (Fig. 7) In three cases, this complication was mild or moderate and did not require surgical intervention. Of the remaining two patients with a severe perforation, one underwent successful laparotomy while the other died 18 hours after ERCP as a result of the complication.

Mortality

Two patients died directly as a result of ERCP, giving an overall mortality of 0.1% in 1550 procedures. One patient died within 24 hours due to a perforation; the other developed severe acute pancreatitis and died fours months later after a protracted illness. A further patient developed mild acute pancreatitis and, although this resolved, she declined fluids and died due to renal failure. If this patient is included as a death due to ERCP, then the mortality from the procedure was 0.2%.

Discussion

ERCP is an indispensable procedure for the management of patients with biliary tract disease. Although its diagnostic value has been reduced by the advent of MRI scanning and endoscopic ultrasound, it still remains useful in identifying lesions of the ampulla and determining the nature of strictures of the biliary tract when combined with histology or cytology. However, its primary value lies in the therapeutic procedures, namely, the removal of common bile duct stones, the alleviation of obstruction by stent insertion and decompression of the biliary tract in the management of post-operative biliary leaks. The correct use of ERCP, though, must involve detailed assessment of patients to avoid unnecessary exposure to serious complications.

The present study describes the practice of ERCP in a district general hospital in the United Kingdom between 1997 and 2006. Its strengths include the large number of procedures reported, the prospective nature of most of the data collected, and the strict intention-to-treat analysis which avoids any selection of patients and, hence, provides a true reflection of the success rates of both diagnostic and therapeutic procedures. However, the study has weaknesses. The data relating to complications were collected retrospectively and relied, therefore, on the accuracy of medical records. While this would be unlikely to be a problem in terms of identifying complications of a moderate or severe degree, it may have led to some inaccuracy in terms of the frequency of minor complications. This is aggravated by the absence of any reliable criteria for the identification of the milder complications of ERCP.

The selection of patients for ERCP

All patients referred for ERCP were assessed in detail by a consultant gastroenterologist and, in 96% of cases, this was carried out by the individual performing the procedure. This contrasts with the results of a recent large audit in the UK which reported that only 16% of endoscopists personally vetted all patients undergoing ERCP. 3 Thus, patients were carefully selected with due attention to their background medical illnesses and their suitability for the procedure; consideration was given to the indications in order to ensure that ERCP was the most appropriate investigation or treatment; and a comprehensive verbal explanation of the procedure was provided, together with written information to be read before giving informed consent.

During the period of the study, the indications for ERCP changed. In particular, after the first two years, patients without objective evidence of biliary tract disease were not considered for the procedure. This was reflected in the findings of the present study which showed a sharp reduction in the number of normal cholangiograms over time as well as a decrease in the rate of pancreatitis – a complication which is recognised to occur more often in patients with abdominal pain alone. 3567 The total number of ERCPs declined between 1997 and 2006, most probably due to both changes in clinical indications and the availability of alternative methods of investigation of the biliary tract, particularly magnetic resonance cholangio-pancreatography. 3

Endoscopic aspects of ERCP

Although difficulties were occasionally encountered with intubation of the oesophagus, all procedures were successful in reaching the stomach. Insertion of the duodenoscope over a guidewire placed with a gastroscope was required in only 0.4% of procedures. Passage of the side-viewer through the pylorus and duodenal bulb was not infrequently hampered by tumour infiltration but this seldom prevented further progression. The descending duodenum was reached in 99.7% and the papilla was successfully identified in 99.3% of ERCPs.

The appearance of the papilla was reported to be normal in 55% of cases, with evidence of previous sphincterotomy being the most commonly observed abnormality. The papilla was involved in a duodenal diverticulum in 12% of cases; this is a similar proportion to that observed previously. 89101112 Although one study reported reduced cannulation rates when the papilla was related to a diverticulum, 9 this finding has not been confirmed. 1112 In the present study, a diverticulum often hindered, but did not prevent, successful cannulation.

Cholangiopancreatography

Between 2001 and 2006, the success rate for cannulation of the common bile duct in 834 patients was 98% on a strict intention-to-treat analysis. This compares favourably with previous reports. The cannulation rates in large studies range from 82-99%; most report less than 95% success and there are often uncertainties regarding exclusions. 1112131415161718192021222324252627 A recent large UK audit reported successful cannulation in 86% of 5,264 procedures while 58% of ERCP endoscopists failed to achieve successful cannulation rates of ≥90%. 3

The proportion of normal cholangiograms decreased from 55% to 16% during the period 1997-2006, a finding that reflected the changing clinical indications for ERCP. The frequency of normal cholangiograms, common bile duct stones and strictures were consistent with previous reports. 2328

Pancreatograms were obtained in 56% of ERCPs, with a reduction in frequency over time. In most cases, filling of the pancreatic duct occurred during the initial attempts to cannulate the common bile duct. Overall, 79% of pancreatograms were normal.

Therapeutic procedures

Sphincterotomy was performed in 54% of patients, a similar proportion to that reported in the literature. 3152930 Pre-cut, or needle-knife sphincterotomy, was attempted in 17% of ERCPs in the present study again consistent with previous reports. 1531323334 Interestingly, the frequency of pre-cut sphincterotomies was inversely proportional to the occurrence of acute pancreatitis. Overall, pre-cut incision allowed deep access to the common bile in 82% of cases and this increased to 90% when the analysis was confined to the period 2001-2006. This figure is higher than most published reports. 31331323334353637383940414243

In the period 2001-2006, the success rates for pre-cut incision (90%) and stent insertion (96%) were high when compared to other reports. 3 Data for stone extraction, however, are more difficult to compare because clearance of the ducts was not always attempted. For example, in frail, elderly patients with extensive duodenal diverticula who might not survive a complication of ERCP, management with a biliary stent would be considered a sensible option compared with the traumatic removal of large stones from the common bile duct. Thus, the rate of 83% for complete clearance of stones from the common bile duct in the present study must be interpreted in the context of decisions not to attempt stone extraction in some patients for sound clinical reasons.

Complications

The overall risk of complications of ERCP – conventionally taken as the aggregate of acute pancreatitis, haemorrhage, perforation and biliary tract infection – is reported in large studies as being in the range of 3-16%, 561415161720232425272935364445464748495051 with an increased risk in therapeutic, compared with diagnostic, procedures. 52 In the present study, complications occurred after 4.7% of ERCPs. This finding was very similar to the 5.1% of complications reported by a recent large audit in the UK. 3

Acute pancreatitis is the most common complication of ERCP although the rates vary considerably. In large series, between 2% and 7% of procedures are followed by pancreatitis. 371415161729444546475253545556575859 However, in randomised trials, where the reporting may be more accurate, 8-15% of procedures are associated with this complication. 226061626364656667686970 Variation in the rate of pancreatitis may also be related to the differences in risk factors which include multiple injections of contrast into the pancreatic duct usually associated with difficult cannulation, 746596065 small calibre ducts, 5971 sphincter of Oddi dysfunction, 467172 female gender 75973 and previous ERCP-induced pancreatitis. 746 Although sphincterotomy and pre-cut have been reported to increase the risk of pancreatitis, 46596072 the findings are not consistent. 5323335387475 It seems, though, that differences in the definition of pancreatitis account for much of the variation in the data. 76 In particular, since upper abdominal pain or increased amylase may each occur after the procedure without pancreatitis, 5860 it follows that the presence of both cannot be assumed to indicate the occurrence of this complication without further evidence. In the present study, 3% of ERCPs were complicated by pancreatitis but, more importantly, only 0.4% of cases were associated with severe pancreatitis, a finding which is similar to that reported elsewhere. 128

Haemorrhage occurs in 0.5-2% of patients undergoing ERCP. 5613141516172527364445474854565777 This complication is, as expected, related to sphincterotomy or pre-cut, with some studies suggesting an increased risk with the latter procedure. 283132333537384075787980 Only 0.5% of ERCPs in the present study were complicated by haemorrhage and the risk of serious bleeding requiring surgery was 0.1%.

ERCP may be complicated by infection, either of the biliary tract or of other sites, including the chest. However, reports in the literature tend to focus on biliary tract infection and, in particular, cholangitis. Most of the large studies report that between 0.5% and 2% of ERCPs are complicated by cholangitis. 617253644454647484951546379818283 In the present study, ERCP was complicated by infection in 0.6% of cases and in only one case (0.1%) was this classified as serious. These findings may be related to the routine use of antibiotic prophylaxis as studies suggest that this reduces the risk of bacteraemia 8284 and, more importantly, clinical sepsis 638586 following ERCP.

Perforation is the least common complication of ERCP. It may be related to endoscopic trauma to the oesophagus, stomach or duodenum – and, in the case of Polya gastrectomy, the jejunum – to sphincterotomy or pre-cut incisions, to manipulation of the common bile duct with balloons or baskets, or to damage to the biliary tract by guidewires. 87 Large series report that between 0.1% and 1.8% of ERCPs are complicated by perforation. 615161725282936454647484951525477798188899091 In the present study, 0.3% of procedures resulted in perforation and, in all cases, this was the result of sphincterotomy or pre-cut. In three cases, this complication was mild or moderate and was managed conservatively in line with accepted practice. 879092 However, of the remaining two patients, one required laparotomy whilst the other died before undergoing surgery. Thus the proportion of ERCPs complicated by serious perforation was 0.1%.

The mortality as a direct consequence of ERCP in the present study was 0.1% although, if a further death less definitely related to the procedure were included, this would increase to 0.2%. This compares favourably with recently published data which reported a procedure-related mortality rate of 0.4%. 3

Trends over time

Scunthorpe General Hospital serves a population of about 160,000 and, given the number of procedures performed annually over recent years, this is equivalent to approximately one ERCP per 1000 of the population per year, a figure similar to that in the recent audit by the British Society of Gastroenterology. 3 As noted above, the number of ERCPs declined between 1997 and 2006. Improved selection of patients and the availability of new techniques for the investigation of the biliary tract resulted in both fewer unnecessary ERCPs – as judged by a reduction in the proportion of normal cholangiograms – and a decline in complications, particularly acute pancreatitis. Interestingly, although the proportions of procedures involving either sphincterotomy or pre-cut increased over time, the rate of complications actually decreased over the same period.

The reduction in the numbers of patients undergoing ERCP has implications for training. The general view is that trainees need to perform between 100 and 200 procedures before they achieve cannulation success rates approaching 80-85% 21939495 and the evidence indicates that, at least in the UK, such a degree of competence is not being achieved. 3 Moreover, the decline the number of ERCPs should lead to fewer consultant gastroenterologists performing this procedure in future.

Conclusions

This study describes the clinical outcomes of a single-handed, consultant-based ERCP service in a district general hospital over a period of nine years and involving 1550 procedures. Data, mostly collected prospectively, show that the consultant gastroenterologist performing ERCP assessed >95% of patients before, and reviewed all of them after, the procedure. The diagnostic and therapeutic success rates – by strict intention-to-treat analysis – were excellent while the risk of complications was low. The data also draw attention to the changes that have taken place over the past decade, particularly in relation to the selection of patients, the decreasing numbers of patients undergoing ERCP, the reduction in normal cholangiograms and the frequency of therapeutic procedures.

Acknowledgements

The authors are grateful to Dr Richard Armstrong and Dr Y Khiyar for his assistance with the data collection and Maria Linnell for her help with the extensive data files.

References

1. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statements 2002;19;1-26.
2. NCEPOD. Scoping our practice; The 2004 Report of the National Confidential Enquiry into Patient Outcome and Death. London: NCEPOD, 2004. http://www.ncepod.org.uk/2004.htm
3. Williams EJ, Taylor S, Fairclough P, Hamlyn A, Logan RF, et al. Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice. Gut 2007;56:821-829.
4. Cotton P & Williams C. Practical Gastrointestinal Endoscopy (Fourth Edition). Blackwell Science, Oxford, England. 1996.
5. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, et al. Complications of endoscopic biliary sphincterotomy. N Eng J Med 1996;335;909-18.
6. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicentre study. Gastrointest Endosc 1998;48;1-10.
7. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, et al. Risk factors for post-ERCP pancreatitis: a prospective multicentre study. Gastrointest Endosc 2001;54;425-34.
8. Leivonen MK, Halttunen JA, Kivilaakso EO. Duodenal diverticulum at endoscopic retrograde cholangiopancreatography, analysis of 123 patients. Hepatogastroenterology 1996; 43; 961-6.
9. Lobo DN, Balfour TW, Iftikhar SY. Periampullary diverticula: consequences of failed ERCP. Ann R Coll Surg Engl 1998;80;326-31.
10. Fogel EL, Sherman S, Lehman GA. Increased selective biliary cannulation rates in the setting of periampullary diverticula: main pancreatic duct stent placement followed by pre-cut biliary sphincterotomy. Gastrointest Endosc 1998;47;396-400.
11. Tham TC, Kelly M. Association of periampullary duodenal diverticula with bile duct stones and with technical success of endoscopic retrograde cholangiopancreatography. Endoscopy 2004;36;1050-3.
12. Vaira D, Dowsett JF, Hatfield AR, Cairns SR, Polydorou AA, et al. Is duodenal diverticulum a risk factor for sphincterotomy? Gut 1989;30;939-42.
13. Kaffes AJ, Sriram PV, Rao GV, Santosh D, Reddy DN. Early institution of pre-cutting for difficult biliary cannulation: a propsective study comparing conventional vs a modified technique. Gastrointest Endosc 2005;62;669-74.
14. Ong TZ, Khor JL, Selamat DS, Yeoh KG, Ho KY, et al. Complications of endoscopic retrograde cholangiopancreatography in the post-MRCP era: a tertiary centre experience. World J Gastroenterol 2005;11;5209-12.
15. Suissa A, Yassin K, Lavy A, Lachter J, Chermech I, et al. Outcome and early complications of ERCP: a prospective single centre study. Hepatogastroenterology 2005;52;352-5.
16. Garcia-Cano LJ, Gonzalez Martin JA, Morillas Arino J, Perez Sola A. Complications of endoscopic retrograde cholangiopancreatography. A study in a small ERCP unit. Rev Esp Enferm Dig 2004;96;163-73.
17. Zinsser E, Hoffmann A, Will U, Koppe P, Bosseckert H. Success and complication rates of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography -a prospective study. Z Gastroenterol 1999;37;707-13.
18. Ramirez FC, Dennert B, Sanowski RA. Success of repeat ERCP by the same endoscopist. Gastrointest Endosc 1999;49;58-61.
19. Ghori A, Hallisey M, Nwokolo C, Loft D, Fraser I. The secret (GTN) of successful ERCP cannulation: a prospective randomised controlled study. J R Coll Surg Edinb 2002;47;634-7.
20. Elizondo J, Gallo S, Valdovinos MA, Paez R. Retrospective evaluation of 500 endoscopic cholangiopancreatographies performed a the Instituto Nacional de al Nutricion “Salvador Zubiran”. Rev Gastroenterol Mex 1989;54; 19-26.
21. Schlup MM, Williams SM, Barbezat GO. ERCP: a review of technical competency and workload in a smal unit. Gastrointest Endsosc 1997;46;48-52.
22. Kaffes AJ, Bourke MJ, Ding S, Alrubaie A, Kwan V, et al. A prospective randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006;64;351-7.
23. Farrell RJ, Mahmud N, Noonan N, Kelleher D, Keeling PW. Diagnostic and therapeutic ERCP: a large single centre’s experience. Ir J Med Sci 2001;170;176-80.
24. Choudari CP, Sherman S, Fogel EL, Phillips S, Kochell A, et al. Success of ERCP at a referral centre after a previously unsuccessful attempt. Gastrointest Endosc 2000;52;478-83.
25. Ciriza C, Dajil S, Jimenez C, Urquiza O, Karpman G, et al. Five year analysis of endoscopic retrograde cholangiopancreatography in the Hospital del Bierzo. Rev Esp Enferm Dig 1999;91;693-702.
26. Tang SJ, Haber GB, Kortan P, Zanati S, Cirocco M, et al. Precut papillotomy versus persistence in difficult biliary cannulation: a prospective randomized trial. Endoscopy 2005;37;58-65.
27. Schreurs WH, Juttmann JR, Stuifbergen WN, Oostvogel HJ, van Vroonhoven TJ. Management of common bile duct stones: selective endoscopic retrograde cholangiography and endoscopic sphincterotomy: short- and long-term results. Surg Endosc 2002;16;1068-72.
28. Mala T, Lunde OC, Nesbakken A, Aadland E, Stiris M. Endoscopic retrograde cholangiopancreatography. A four year retrospective study. Tidsskr Nor Laegeforen 2000;120;560-2.
29. Barthet M, Lesavre N, Desjeux A, Gasmi M, Berthezene P, et al. Complications of endoscopic sphincterotomy: results from a single tertiary referral centre. Endoscopy 2002;34;991-7.
30. Mehta SN, Pavone E, Barkun AN. Outpatient therapeutic ERCP: a series of 262 consecutive cases. Gastrointest Endosc 1996;44;443-9.
31. Gholson CF, Favrot D. Needle knife papillotomy in a university referral practice. Safety and efficacy of a modified technique. J Clin Gastroenterol 1996;23;177-80.
32. Bruins Slot W, Schoeman MN, Disario JA, Wolters F, Tytgat GN, et al. Needle-knife sphincterotomy as a pre-cut procedure: a retrospective evaluation of efficacy and complications. Endoscopy 1996;28;334-9.
33. Katsinelos P, Mimidis K, Paroutoglou G, Christodoulou K, Pilpildis I, et al. Needle-knife papillotomy: a safe and effective technique in experienced hands. Hepatogastroenterology 2004;51;349-52.
34. O'Connor HJ, Bhutta AS, Redmond PL, Carruthers DA. Suprapapillary fistulosphincterotomy at ERCP: a prospective study. Endoscopy 1997;29;266-70.
35. Ahmad I, Khan AA, Alam A, Butt AK, Shafqat F, et al. Precut papillotomy outcome. J Coll Phsycians Surg Pak 2005;15;701-3.
36. Koklu S, Parlak E, Yuksel O, Sahin B. Endoscopic retrograde cholangiopancreatography in the elderly: a prospective and comparative study. Age Ageing 2005;34;572-7.
37. Espinel Diez J, Vivas Alegre S, Munoz Nunez F, Dominguez Carbajo A, Villanvea Pavon R, et al. Needle-knife sphincterotomy for biliary access: a prospective study. Gastroenterol Hepatol 2005;28;369-74.
38. Gullichsen R, Lavonius M, Laine S, Gronroos J. Needle-knife assisted ERCP. Surg Endosc 2005;19;1243-5.
39. Kasmin FE, Cohen D, Batra S, Cohen SA, Siegel JH. Needle-knife sphincterotomy in a tertiary referral centre: efficacy and complications. Gastrointest Endosc 1996;44;48-53.
40. Kahaleh M, Tokar J, Mullick T, Bickston SJ, Yeaton P. Prospective evaluation of pancreatic sphincterotomy as a precut technique for biliary cannulation. Clin Gastroenterol hepatol 2004;2;971-7.
41. Dhir V, Swaroop VS, Mohandas KM, Jagannath P, Desouza LJ. Precut papillotomy using a needle knife: experience in 100 patients with malignant obstructive jaundice. Indian J Gastroenterol 1997;16;52-3.
42. Rollhauser C, Johnson M, Al-Kawas FH. Needle-knife papillotomy: a helpful and safe adjunct to endoscopic retrograde cholangiopancreatography in a selected population. Endoscopy 1998;30;691-6.
43. Zhou PH, Yao LQ, Xu MD, Zhong YS, Gao WD, et al. Application of needle-knife in difficult biliary cannulation for endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int 2006;5;590-4.
44. Christensen M, Matzen P, Schulze S, Rosenberg J Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60;721-31.
45. Guidi M, Baldoni F, Goldin E, Wengrower D, Bologna A, et al. Complications of endoscopic retrograde cholangiopancreatography. Acta Gastroenterol 2003;33;133-7.
46. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56;652-6.
47. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicentre study. Am J Gastroenterol 2001;96;417-23.
48. Coppola R, Riccioni ME, Ciletti S, Cosetino L, Coco C, et al. Analysis of complications of endoscopic sphincterotomy for biliary stones in a consecutive series of 546 patients. Surg Endosc 1997;11;129-32.
49. Ragunath K, Thomas LA, Cheung WY, Duane PD, Richards DG, et al. Objective evaluation of ERCP procedures: a simple grading scale for evaluating technical difficulty. Postgrad Med J 2003;79;467-70.
50. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography. A study of 10,000 cases. Gastroenterology 1976;70;314-20.
51. Mahnke D, Chen YK, Antillon MR, Brown WR, Maltison R, et al. A prospective study of complications of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in an ambulatory endoscopy centre. Clin Gastroenterol hepatol 2006;4;924-30.
52. Halme L, Doepel M, von Numers H, Edgren J, Ahonen J. Complications of diagnostic and therapeutic ERCP. Ann Chir Gynaecol 1999;88;127-31.
53. Frank CD, Adler DG. Post-ERCP pancreatitis and its prevention. Nat Clin Pract Gastroenterol Hepatol 2006;3;680-8.
54. Pungpapong S, Kongkam P, Rerknimitr R, Kullavanijaya P. Experience on endoscopic retrograde cholangiopancreatography at a tertiary referral centre in Thailand: risks and complications. J Med Assoc Thai 2005;88;238-46.
55. Laasch HU, Tringali A, Wilbraham L, Marriott A, England RE, et al. Comparison of standard and steerable catheters for bile duct cannulation in ERCP. Endoscopy 2003;35;669-74.
56. Lal D, Lane M, Wong P. Complications of endoscopic retrograde cholangiopancreatography. N Z Med J 2003;116;U496.
57. Gomez Ponce RL. Early complications of endoscopic retrograde cholangiopancreatography performed January 1998 to December 2000 in Peru. Rev Gastroenterol Peru 2002;22;33-43.
58. Christoforidis E, Goulimaris I, Kanellos I, Tsalis K, Demetriades C et al. Post-ERCP pancreatitis and hyperamylasaemia: patient-related and operative factors. Endoscopy 2002;34;286-92.
59. Dickinson RJ, Davies S. Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient factors. Eur J Gastroenterol Hepatol 1998;10;423-8.
60. Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, et al. Prophylaxis of ERCP-related pancreatitis: a randomized controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2004;2;713-8.
61. Rabenstein T, Fischer B, Wiessner V, Schmidt H, Radespiel-Troger M, et al. Low molecular weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 2004;59;606-13.
62. Moreto M, Zaballa M, Casado I, Merino O, Rueda M, et al. Transdermal glyeryl trinitrate for prevention of post-ERCP pancreatitis: a randomised double-blind trial. Gastrointest Endosc 2003;57;1-7.
63. Raty S, Sand J, Pulkkinen M, Matikainen M, Nordback I. Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg 2001;5;339-45.
64. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicentre randomized controlled trial. Gastrointest Endosc 2002;55;470-5.
65. Budzynska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E, et al. A prospective randomized placebo-controlled trials of prednisolone and allupurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33;766-72.
66. Bergman JJ, van Berkel AM, Bruno MJ, Fockens P, Rauwsca, et al. Is endoscopic balloon dilatation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasaemia? Endoscopy 2001;33;416-20.
67. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120;498-505.
68. Hardt PD, Kress O, Fadgyas T, Doppl W, Schnell-Kretschm H, et al. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res 2000;5;165-70.
69. Arvanitidis D, Hatzipanayiotis J, Koutsounopoulos G, Frangou E. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasaemia after diagnostic and therapeutic ERCP. Hepatogastroenterology 1998;45;248-52.
70. Dumot JA, Conwell DL, O'Connor JB, Ferguson DR, Vargo JJ, et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomised, multicentre placebo-controlled clinical trial. Am J Gastroenterol 1998;93;61-5.
71. Testoni PA, Bagnolo F, Andriulli A, Bernasconi G, Crotta S, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicentre randomized controlled trial. Aliment Pharmacol Therap 2001;15;965-72.
72. Baillie J. Predicting and preventing post-ERCP pancreatitis. Curr Gastroenterol Rep 2002;4;112-9.
73. Murray WR. Reducing the incidence and severity of post ERCP pancreatitis. Scand J Surg 2005;94;112-6.
74. Arcidiacono R, Gambitta P, Rossi A, Grosso C, Bini M, et al. The use of long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 1994;26;715-8.
75. Bergman JJ, Rauws EA, Fockens P, van Berkel AM, Bossuyt PM, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997;349;1124-9.
76. Testoni PA, Bagnolo F, Natale C, Primignani M. Incidence of post-endoscopic retrograde cholangiopancreatography/ sphincterotomy pancreatitis depends upon definition criteria. Dig Liver Dis 2000;32;412-8.
77. Chong VH, Yim HB, Lim CC. Endoscopic retrograde cholangiopancreatography in the elderly: outcomes, safety and complications. Singapore Med J 2005;46;621-6.
78. Baron TH, Harewood GC. Endoscopic balloon dilatation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2004;99;1455-60
79. Wojtun S, Gil M, Gil J. Recognition of ERCP-induced pancreatitis in patients with choledocholithiasis by an analysis of laboratory findings. Hepatogastroenterology 2000;47;550-3.
80. Kuran S, Parlak E, Oguz D, Cicek B, Disibeyaz S, et al. Endoscopic sphincterotomy-induced haemorrhage: treatment with heat probe. Gastrointest Endosc 2006;63;506-11.
81. Pasanen P, Partanen K, Pikkarainen P, Alhaua E, Pirinen A, et al. Complications of endoscopic retrograde cholangiopancreatography in jaundiced and cholestatic patients. Ann Chir Gynaecol 1992;81:28-31.
82. Davis AJ, Kolios G, Alveyn CG, Robertson DA. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 1998;12;207-11.
83. Mehal WZ, Culshaw KD, Tillotson GS, Chapman RW. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol 1995;7;841-5.
84. Sauter G, Grabein B, Huber G, Mannes GA, Ruckdeschel G, et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990;22;164-7.
85. Siegman-Igra Y, Spinrad S, Rattan J. Septic complications following endoscopic retrograde cholangiopancreatography: the experience in Tel Aviv Medical Centre. J Hosp Infect 1988;12;7-12.
86. Byl B, Deviere J, Struelens MJ, Roucloux I, De Coninck A, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995;20;1236-40.
87. Enns R, Eloubeidi MA, Mergener K, Jowell PS, Branch MS, et al. ERCP-related perforations: risk factors and management. Endoscopy 2002;34;293-8.
88. Kaffes AJ, Hourigan L, De Luca N, Byth K, Williams SJ, et al. Impact of endoscopic intervention in 100 patients with suspected post-cholecystectomy bile leak. Gastrointest Endosc 2005;61;269-75.
89. Preetha M, Chung YF, Chan WH, Ong HS, Chow PK, et al. Surgical management of endoscopic retrograde cholangiopancreatography-related perforations. ANZ J Surg 2003;73;1011-4.
90. Guitron-Cantu A, Adalid-Martinez R, Gutierrez-Bermuez JA. Conservative management of duodenal perforation following endoscopic sphincterotomy of papilla of Vater. Rev Gastroenterol Mex 2003;68;6-10.
91. Zissin R, Shapiro-Feinberg M, Oscadchy A, Pomeranz I, Leichtmann G, et al. Retroperitoneal perforation during endoscopic sphincterotomy: imaging findings. Abdo Imaging 2000;25;279-82.
92. Stapfer M, Selby RR, Stain SC, Katkhouda N, Parekh, et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy. Ann Surg 2000;232;191-8.
93. Uradomo LT, Lustberg ME, Darwin PE. Effect of physician training on fluoroscopy time during ERCP. Dig Dis Sci 2006;51;909-14.
94. Vitale GC, Zavaleta CM, Vitale DS, Binford JC, Tran TC, et al. Training surgeons in endoscopic retrograde cholangiopancreatography. Surg Endosc 2006;20;149-52.
95. Moreira V, Martin-de-Argilla C, Merono E, Garcia Plaza A. Training in diagnostic and therapeutic ERCP. Rev Esp Enferm Dig 1994;86;901-7.

Author Information

James Penston, MD
Consultant Physician/Gastroenterologist, Scunthorpe General Hospital

Paul Southern, MB, ChB
Specialist Registrar in Gastroenterology, Scunthorpe General Hospital

Victoria Penston
Medical Student, Liverpool University Medical School

Jeremy Daws
Audit Department, North Lincolnshire and Goole NHS Trust

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy